FDA Inspection 1323652 — Charles River Laboratories, Inc.
The FDA completed an inspection of Charles River Laboratories, Inc. on May 1, 2026 in Saint-Laurent. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 1, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint-Laurent (Canada)
Additional Details
Bioanalytical BA/BE